TYK2 Inhibition in Paradoxical Psoriasis
Clinical trial NCT06281106 · TERMINATED
Trial details
- NCT number
- NCT06281106
- Sponsor
- Prof Curdin Conrad
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2025-03-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.